Financhill
Back

Alimentation Couche-Tard Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
42

ATD.TO
Alimentation Couche-Tard

Last Price:
76.94
Seasonality Move:
9.16%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
40.44
Seasonality Move:
-0.9%
Sell
42
Alimentation Couche-Tard (ATD.TO) is a Sell

Is Alimentation Couche-Tard a Buy, Sell or Hold?

  • The current Alimentation Couche-Tard [ATD.TO] share price is $79.50. The Score for ATD.TO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ATD.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATD.TO Stock Price Chart

What is Alimentation Couche-Tard's stock price today?

  • The Alimentation Couche-Tard share price today is $79.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATD.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

ATD.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 56.73 Buy
Chaikin Money Flow: 1082755 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.21 - 80.01) Buy
Bollinger Bands (100): (75.63 - 82.27) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

ATD.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.3 Buy
20-day SMA: 78.36 Buy
50-day SMA: 77.31 Buy
200-day SMA: 77.56 Buy
8-day EMA: 78.07 Buy
20-day EMA: 78.01 Buy
50-day EMA: 77.91 Buy
200-day EMA: 76.31 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Alimentation Couche-Tard Earnings Growth & ATD.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.43 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Alimentation Couche-Tard Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):